Blood Immune Cell Biomarkers in Lung Cancer

Clinical and Experimental Immunology- United Kingdom

doi 10.1111/cei.13219

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Beyond Chemotherapy: Emerging Biomarkers and Therapies as Small Cell Lung Cancer Enters the Immune Checkpoint Era

Cancer
Cancer ResearchOncology
2019English

Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?

Cancers
Cancer ResearchOncology
2019English

Blood-Based Biomarkers for Precision Medicine in Lung Cancer: Precision Radiation Therapy

Translational Lung Cancer Research
Oncology
2017English

Investigation of Metabolomic Blood Biomarkers for Detection of Adenocarcinoma Lung Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2015English

Neutrophils Dominate the Immune Cell Composition in Non-Small Cell Lung Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Peripheral Blood Markers Identify Risk of Immune‐Related Toxicity in Advanced Non‐Small Cell Lung Cancer Treated With Immune‐Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Advances in Immune Therapy for Non Small Cell Lung Cancer

Medical Diagnosis
2016English

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer

World Journal of Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy